The report comes months after U.S. President Joe Biden signed a bill into law requiring declassification of intelligence related to the pandemic’s potential links to a Wuhan lab.
A new analysis of samples taken from a market in Wuhan during the early days of the pandemic are the strongest evidence yet that the COVID-19 virus jumped from animals to humans.
Scientific safety has re-emerged as a high-stakes global issue after the U.S. suggested it had intelligence showing a lab leak was the most likely origin of the COVID-19 pandemic.
The U.S. response has gradually shifted to the background, though the uptake of the latest booster shot remains modest and about 500 people are dying each day from COVID-19 in the nation.
Nearly three years since the beginning of the outbreak, and after endless debate about COVID-19's origins, the answers we’re getting aren’t pat, definitive or satisfying.
COVID-19 forced governments to revamp their pandemic response programs. Now monkeypox is putting those upgrades to the test — and they’re falling short.
Despite rules that require travelers to produce a negative COVID-19 test result in order to enter the U.S., the former nail salon chain's testing service routinely finds positive cases.
Major pharmaceutical firms are seeking to strike a balance between international opprobrium over Russia’s invasion of Ukraine and the needs of sick patients.
While research continues, Pfizer will evaluate the new hybrid shot against one specific to omicron and determine which should move forward by March, the firm's CEO has said.
Pfizer has been first across the finish line in nearly every leg of the COVID-19 vaccine race, but Moderna executives say their company’s mRNA technology gives it an advantage.
